Don’t Wait—Uncover the Clinical Endpoints that Will Matter to Payers and HCPs

It’s never too early in the research and development (R&D) process to identify and ...

New Strategies for the Now Everywhere Point of Care

The idea of what constitutes the “point of care” is evolving. At its heart, ...

Making Sense of the Latest Changes to the Market Access Landscape

No one has ever described the pharma market access landscape as simple or easy ...

Two Key Questions About Payer Strategies in 2023

PM360 asked experts in developing market access strategies about how the Inflation Reduction Act ...

Phishing Scams and Cybersecurity: The Good and Bad of AI

It is no secret artificial intelligence (AI) has become increasingly powerful and more widely ...

Healthcare Watch April 2023

Patient Pages: How Healthcare Costs Affect Insured Patients Today A new study shows an ...

A close-up of an eyeball as the person administers an eyedrop.

Industry Briefs April 2023

Grifols and Selagine Tackle Dry Eyes The two eyecare leaders have entered a research, ...

The Focus and Challenges for Access in Emerging Markets

When comparing the challenges presented in emerging markets with more mature markets, the obvious ...

Improve Your Health, Meet in Person

The health-conscious among us pay special attention to actively managing our sleep, exercise, vitamins, ...

Identifying Copay Accumulator Impact: Winning the Race for Patient Access

The pharmaceutical supply chain is so complex that it provides the perfect camouflage for ...

Causal AI Is Here to Tell You the Reasons Why—Behind Anything

While generative artificial intelligence (AI) has been grabbing most of the attention thanks to ...